Are you ready to explore how Germany’s new Medical Research Act will reshape the European clinical trial landscape? This groundbreaking reform is designed to streamline approvals, reduce bureaucracy, and accelerate trial execution – unlocking Germany’s full potential as a key hub for innovation, with lessons to be learned for global trial organizers.
Join experts from vfa, Boehringer Ingelheim, Sanofi, BMS and Clariness as we break down:
Don’t miss this opportunity to stay ahead of regulatory changes and optimize your clinical trial footprint in Europe. Register now!
We will be joined by guest speakers from international sponsors, with different regional headquarters, offering a varied viewpoint, including:
Speakers:
We will be joined by guest speakers from international sponsors, with different regional headquarters, offering a varied viewpoint, including:
